GSE161287
Epigenetically defined therapeutic targeting in H3G34R/V high-grade gliomas [ChIP-Seq]
H3.3G34R/V hemispheric gliomas carry a dismal prognosis as current treatments including radio/chemotherapy are not curative. We undertook a systematic and comprehensive epigenetic approach to define therapeutic dependencies in H3.3G34R/V gliomas. Overall design: Three biological replicates were analyzed for each of 3 conditions